Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gemini Space Station Inc (GEMI) vs Pfizer Inc (PFE) Price & Performance

Gemini Space Station IncTrade
Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Gemini Space Station Inc vs Pfizer Inc — how do they compare? Gemini Space Station Inc trades at $4.02 (market cap $512.05M), while Pfizer Inc trades at $26.28 (market cap $151.73B). The key difference: Pfizer Inc is far larger — about 296.3× Gemini Space Station Inc's market cap, and Pfizer Inc pays a 6.46% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals.

GEMIPFE
Market Cap
$512.05M$151.73B
Sector
TechnologyHealth
52-Week High
$32.52$28.56
52-Week Low
$3.90$23.60
Enterprise Value
$502.04M$203.22B
Volume
29,869,932
Dividend Yield
6.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gemini Space Station Inc

GEMI trades at $4.04, down 1.7% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $582.81M in 2025 on revenue of $179.57M, with negative gross and net income margins. Recent news includes a $100M investment from Winklevoss Capital and multiple class-action lawsuits alleging securities law violations.

The outlook remains challenging due to persistent losses and legal overhangs, though analyst consensus suggests a potential upside to $6.33. Key risks include ongoing unprofitability, competitive pressures in financial services, and regulatory scrutiny. Investment opportunity hinges on the company's ability to achieve profitability and navigate legal challenges.

Pfizer Inc

Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.

The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gemini Space Station Inc

Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.

Read more on GEMI

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE